ADYX — Adynxx Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
C2014 December 31st | R2015 December 31st | R2016 December 31st | R2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.79 | 12.2 | 16.3 | 2.02 | 2.22 |
Cost of Revenue | |||||
Gross Profit | 0.998 | 6.22 | 9.15 | 0.178 | 0.496 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.2 | 41.7 | 48.5 | 6.96 | 9.22 |
Operating Profit | -25.4 | -29.5 | -32.2 | -4.94 | -7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.4 | -28.9 | -33.8 | -4.24 | -7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.4 | -27.2 | -33 | -4.24 | -7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -25.4 | -26 | -28.2 | -25.7 | -8.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.4 | -26 | -28.2 | -25.7 | -8.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -103 | -65.9 | -49.6 | -6.19 | -5.22 |